Endocrine tumours (Q65506): Difference between revisions

← Older edit

@@ Property / Canary Token @@
+dki-india-ID_1909613405
@@ Property / Canary Token: dki-india-ID_1909613405 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank

Latest revision as of 13:13, 14 August 2026

Endocrine tumours, also referred to as neuroendocrine tumours (NETs), are defined by a common phenotype which is characterised by the expression of general markers (neuron specific enolase, chromogranin, synaptophysin) and hormone secretion products. These tumours may be localised in any part of the body and the most common localisations are the lungs, ileus, appendix, or rectum. Neuroectodermal NETs include medullary thyroid cancer, pheochromocytoma, and paraganglioma.

Language	Label	Description	Also known as
default for all languages	ID_1909613405
English	Endocrine tumours	Endocrine tumours, also referred to as neuroendocrine tumours (NETs), are defined by a common phenotype which is characterised by the expression of general markers (neuron specific enolase, chromogranin, synaptophysin) and hormone secretion products. These tumours may be localised in any part of the body and the most common localisations are the lungs, ileus, appendix, or rectum. Neuroectodermal NETs include medullary thyroid cancer, pheochromocytoma, and paraganglioma.